All Articles
The number of women screened for cervical cancer in the United States declined between 2005 and 2019, with lack of knowledge about the need for screening cited as the primary reason for not being up to date, according to findings from a recent population-based, cross-sectional study. Read More ›
Mitesh J. Borad, MD, Mayo Clinic College of Medicine and Science, Phoenix, AZ, delivered an expert Keynote Perspective at the Third Annual CCA Summit, highlighting genomic profiling as the standard of care in the management of patients with intrahepatic cholangiocarcinoma (CCA), with liquid biopsy becoming the tool of choice for genomic profiling in biliary tract cancers. Read More ›
The No Surprises Act, which went into effect on January 1, 2022, provides balance billing protections for patients while simultaneously creating new ways for them to understand their financial responsibilities. Read More ›
The following clinical trials represent a selection of key studies currently recruiting patients with renal-cell carcinoma for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›
Dr Steven Rowe continues his discussion of PYLARIFY® (piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients. Read More ›
Amgen offers assistance to patients taking Kanjinti through Amgen Assist 360, Amgen FIRST STEP, and the Amgen Safety Net Foundation. Read More ›
As the medical field grows increasingly complex and services continue to move to the outpatient setting, a focus on health literacy becomes more and more important. Read More ›
AstraZeneca, through its Access 360 and AZ&Me programs, offers a range of patient assistance to help streamline access and reimbursement for select AstraZeneca medicines. Read More ›
Through its Access Support program, Bristol Myers Squibb (BMS) offers a variety of options to help provide eligible patients access to its oncology medications and reimbursement support services. The program offers benefits reviews, prior authorization assistance, and appeal process support, as well as an easy-to-initiate copay assistance process and information on financial support. The support offered varies based on the patient’s prescribed medication and insurance status. Read More ›
Daiichi-Sankyo and AstraZeneca offer the Enhertu4U support program to provide information and assistance to patients who have been prescribed Enhertu. Read More ›